April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Quantitative Analysis Of Macular Perfusion And/or Ischemia In Patients With Macular Edema Using Ultra-wide Field Fluorescein Angiography
Author Affiliations & Notes
  • Michael D. Bennett
    Retina Institute of Hawaii, Honolulu, Hawaii
  • Karl E. Waite
    Ophthalmology,
    Retina Institute of Hawaii, Honolulu, Hawaii
  • Footnotes
    Commercial Relationships  Michael D. Bennett, Optos plc (C); Karl E. Waite, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1722. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michael D. Bennett, Karl E. Waite; Quantitative Analysis Of Macular Perfusion And/or Ischemia In Patients With Macular Edema Using Ultra-wide Field Fluorescein Angiography. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1722.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To assess and quantify the fluorescein angiographic macular findings of patients with macular edema pre and one month post Anti-VEGF injection, and to determine if this new concept for fluorescein angiography could correlate with OCT.

 
Methods:
 

A novel, prospective Quantative Analysis was performed on the ultra-widefield fluorescein angiograms (Optos plc.) of 20 subjects with macular edema associated with AMD, DR & RVO at baseline and one month post intra-vitreal injection of Anti-VEGF. The maximum luminosity achieved by 1st order vessels in the transit phase was used to normalize luminance values obtained throughout the fluorescein angiogram within a grid centered on the fovea and extending to a diameter of 6mm. Analysis was performed to determine if gamma normalization and luminance analysis in the macular region correlated with OCT thickness.

 
Results:
 

A value based on luminance was determined for each pixel in the macular grid, allowing color maps to be created. From the pre and post anti-VEGF fluorescein angiograms it was possible to develop luminance difference maps which were compared to OCT (Heidelberg Engineering) on the same patients.

 
Conclusions:
 

Assessing perfusion and/or ischemia in the macula by quantification of normalised luminance appears to be a valuable clinical adjunct in determining the efficacy of anti-VEGF therapy in patients with macular edema.  

 
Keywords: imaging/image analysis: clinical • edema • macula/fovea 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×